Literature DB >> 19109774

Breast cancer in Asia.

Cheng-Har Yip1.   

Abstract

Breast cancer is the commonest cancer in most countries in Asia. The incidence rates remain low, although increasing at a more rapid rate than in western countries, due to changes in the lifestyle and diet. There are many differences between breast cancer in Asia compared with western countries. The mean age at onset is younger than in the west, and unlike the west, the age-specific incidence decreases after the age of 50 years. Because there is no population-based breast cancer screening program in the majority of Asian countries, the majority of patients present with advanced disease. There is a higher proportion of hormone receptor-negative patients, and some evidence that the cancers in Asia are of a higher grade. Most of the Asian countries are low- and middle-income countries, where access to effective care is limited. Because of the late detection and inadequate access to care, survival of women with breast cancer in Asia is lower than in western countries. Improving breast health in most of the Asian countries remains a challenge that may be overcome with collaboration from multiple sectors, both public and private.

Entities:  

Mesh:

Year:  2009        PMID: 19109774     DOI: 10.1007/978-1-59745-416-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Comparative cellular and molecular analysis of cytotoxicity and apoptosis induction by doxorubicin and Baneh in human breast cancer T47D cells.

Authors:  P Fathi Rezaei; Sh Fouladdel; Silvia Cristofanon; S M Ghaffari; G R Amin; E Azizi
Journal:  Cytotechnology       Date:  2011-08-05       Impact factor: 2.058

2.  Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.

Authors:  Geok-Hoon Lim; Puay-Hoon Tan; Ana Richelia Jara-Lazaro; Aye Aye Thike; Wey-Cheng Sim; Von-Bing Yap; George Wai-Cheong Yip
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

3.  Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy.

Authors:  Bhumsuk Keam; Seock-Ah Im; Sohee Park; Byung-Ho Nam; Sae-Won Han; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Wonshik Han; Dong-Wan Kim; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Yung-Jue Bang
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-30       Impact factor: 4.553

4.  Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry.

Authors:  Melinda L Telli; Ellen T Chang; Allison W Kurian; Theresa H M Keegan; Laura A McClure; Daphne Lichtensztajn; James M Ford; Scarlett L Gomez
Journal:  Breast Cancer Res Treat       Date:  2010-10-19       Impact factor: 4.872

5.  PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy.

Authors:  Yoon Ah Cho; Seung Yeon Ko; Yong Joon Suh; Sanghwa Kim; Jung Ho Park; Hye-Rim Park; Jinwon Seo; Hyo Geun Choi; Ho Suk Kang; Hyun Lim; Ha Young Park; Mi Jung Kwon
Journal:  Curr Oncol       Date:  2022-04-19       Impact factor: 3.109

6.  Breast cancer in South East Asia: comparison of presentation and outcome between a middle income and a high income country.

Authors:  Nakul Saxena; Mikael Hartman; Nirmala Bhoo-Pathy; Jennifer N W Lim; Tar-Ching Aw; Philip Iau; Nur Aishah Taib; Soo-Chin Lee; Cheng-Har Yip; Helena M Verkooijen
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

7.  Nomogram for predicting breast conservation after neoadjuvant chemotherapy.

Authors:  Min Kyoon Kim; Wonshik Han; Hyeong-Gon Moon; Soo Kyung Ahn; Jisun Kim; Jun Woo Lee; Ju-Yeon Kim; Taeryung Kim; Kyung-Hun Lee; Tae-Yong Kim; Sae-Won Han; Seock-Ah Im; Tae-You Kim; In Ae Park; Dong-Young Noh
Journal:  Cancer Res Treat       Date:  2014-09-04       Impact factor: 4.679

8.  Predicting mammography stage of adoption among Iranian women.

Authors:  Parvaneh Taymoori; Tanya Berry; Fariba Farhadifar
Journal:  J Educ Health Promot       Date:  2012-07-30

Review 9.  Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.

Authors:  Hui Miao; Mikael Hartman; Nirmala Bhoo-Pathy; Soo-Chin Lee; Nur Aishah Taib; Ern-Yu Tan; Patrick Chan; Karel G M Moons; Hoong-Seam Wong; Jeremy Goh; Siti Mastura Rahim; Cheng-Har Yip; Helena M Verkooijen
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

10.  Incidence and mortality of female breast cancer in the Asia-Pacific region.

Authors:  Danny R Youlden; Susanna M Cramb; Cheng Har Yip; Peter D Baade
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.